Trials, publications and grants since Nov 2024.
Publication
Serine-65 phosphorylated ubiquitin associates with soluble tau and seeding activity in Alzheimer's disease.
Nature communications, Oct 2026
Publication
APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer's disease.
Nature communications, Oct 2026
Publication
Distinct and shared multimodal neuroimaging patterns in clinical frontotemporal dementia syndromes.
Brain communications, Sept 2026
Publication
Chromosome X-wide association study in multiple system atrophy identifies sex-differential risk loci.
Brain : a journal of neurology, Sept 2026
Publication
Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer's disease.
Brain communications, Aug 2026
Publication
TAF15 amyloids propagate via defined motifs in a prion-like fashion.
Nature communications, Jul 2026
Publication
Evaluating MAPT p.A152T as a risk factor for the 3R tauopathy Pick's disease.
Brain communications, Jul 2026
Publication
Seeing Invisible Oligomers: Rethinking α-Synuclein Pathology Through Proximity Ligation Assay.
Movement disorders : official journal of the Movement Disorder Society, Apr 2026
Publication
Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease.
Annals of neurology, Apr 2026
Publication
Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism.
Annals of neurology, Mar 2026
Publication
A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusions.
Nature genetics, Mar 2026
Publication
Integrative epigenomic landscape of Alzheimer's Disease brains reveals oligodendrocyte molecular perturbations associated with tau.
Nature communications, Mar 2026
Publication
Novel Aggressive Subtype of Multiple System Atrophy Identified by Unsupervised Machine Learning.
Annals of neurology, Jan 2026
Publication
In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils.
ACS chemical neuroscience, Jan 2026
Publication
White matter hyperintensities in the deep cerebral venous territory differ between subcortical and cortical 4-repeat tauopathies.
Parkinsonism & related disorders, Dec 2025
Publication
Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease.
Annals of neurology, Nov 2025
Publication
Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies.
Molecular neurodegeneration, Nov 2025
Publication
TDP-43 nuclear loss in FTD/ALS causes widespread alternative polyadenylation changes.
Nature neuroscience, Oct 2025
Publication
Cortical variant multiple sclerosis presenting clinically as Lewy body dementia.
Journal of neuropathology and experimental neurology, Sept 2025
Publication
Author Correction: Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer's disease copathologies.
NPJ Parkinson's disease, Jul 2025
Publication
Methylome analysis of FTLD patients with TDP-43 pathology identifies epigenetic signatures specific to pathological subtypes.
Molecular neurodegeneration, Jul 2025
Publication
Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice.
Nature communications, May 2025
Publication
Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer's disease copathologies.
NPJ Parkinson's disease, May 2025
Publication
Characterizing the expression profile of 3R tau pathology in Pick's disease.
Science advances, May 2025